Massachusetts General Hospital Founded in 1811, the Massachusetts General Hospital (MGH) is the third-oldest general hospital in the United States. This world-renowned medical center offers sophisticated diagnostic and therapeutic care in virtually every specialty and subspecialty of medicine and surgery. In July 2005, the MGH was named one of the country's best hospitals by U.S. News and World Report for the sixteenth year, ranking third nationwide.
The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of nearly $463 million. It is the oldest and largest teaching hospital of the Harvard Medical School, and nearly all of the hospital's active staff physicians are on the Harvard Medical School faculty. www.mgh.harvard.edu Back to top
Draper Laboratory Draper Laboratory is a non-profit, research and development laboratory dedicated to serving the national interest in applied research, engineering development, advanced technical education, and technology transfer. Areas of technology development include guidance, navigation, and control; highly reliable embedded software; autonomous systems; miniature, low-power electronics; and biomedical engineering. www.draper.com Back to top
The ExOne Company The ExOne Company emerged from Extrude Hone Corporation when that firm was acquired by Kennametal, Inc. in February, 2005 from ExOne's Chief Executive Officer, Larry Rhoades.
ExOne's principal activities are the development and application of advanced manufacturing processes, with a specific focus on digital free-form fabrication and micro-machining. The company is well known for transitioning new scientific knowledge into new tools that enable new concept products in a wide range of industries from defense, to automotive, to dental and medical products. It actively collaborates with more than two dozen leading universities in the U.S. and abroad and has active process development efforts supported by the DOD, NIST and NSF. Its customers include many of the world's largest manufacturers. The company has operations in the U.S., Germany and Japan. www.exone.com Back to top
BioEngine BioEngine has pioneered a revolutionary platform of bioengineered, implantable liver assist and replacement devices designed to meet the urgent need for therapy of acute and chronic liver disease and failure.
In the U.S. alone, one in ten, or 25 million people suffer from liver diseases, including viral hepatitis, cirrhosis, and cancer of the liver. Our lead candidate, an implantable bioengineered liver assist device, will work with the recipient's damaged liver to augment liver function and mitigate the wide variety of side effects from chronic liver disease.
BioEngine's ground-breaking technologies were conceived, developed and patented over the past 20 years through extensive research headed by Dr. Joseph Vacanti, a pioneer in the organ engineering field, in collaboration with Massachusetts General Hospital, Draper Laboratory, and The ExOne Company. This unique multi-disciplinary scientific, clinical, and MicroElectroMechanical Systems (MEMS) fabrication capability has served as the backbone of our technological advances and proven essential to the creation of the world's first vascularized, implantable bioengineered liver assist device incorporating human liver cells - which mimics human function and condition. www.bioengine.biz Back to top
BrandIntent BrandIntent specializes in shaping leadership brands and executing high-profile programs for organizations that must rapidly change perceptions. The company provides a hybrid blend of strategy, creative and business capabilities to accelerate the delivery of comprehensive brand initiatives for leading technology, consumer and professional service organizations. Its success in blending creativity and strategy extends to the design and execution of integrated marketing initiatives that deploy the most effective print, web and eMarketing channels to optimize the return from marketing resources that must support multiple business and product lines, customer segments and key partners. www.brandintent.com Back to top
Center for Regenerative Medicine Stem cell research is a rapidly growing and diversifying field of study that is generating tremendous advances in our understanding of disease and our capacity to cure chronic diseases. The Center for Regenerative Medicine (CRM) at Massachusetts General Hospital strives to bridge the gap between basic science and the clinical setting. The Center for Regenerative Medicine is working to develop therapies that can be applied to the treatment of chronic diseases such as leukemia, lymphoma, various cancers, diabetes and other illnesses rooted in tissue damage. Stem cell research has already resulted in remarkable progress in bone marrow transplantation, saving thousands of lives over the past four decades. Expanding those successes into the treatments for other serious diseases is the vision and the goal of stem cell research at the Center for Regenerative Medicine. Every day, some of the world's most talented scientists come to work in the labs at the Center for Regenerative Medicine. These researchers are talented, driven and creative in their strategies for understanding the cellular basis of disease and mechanisms for tissue regeneration. Many of these investigators hold MD and PhD degrees from top universities and our trainees, fellows and students have exceptional backgrounds in genetics, cancer biology, biochemistry, cell biology and other fields. The Co-Directors of the Center for Regenerative Medicine are Dr. Joseph Vacanti and Dr. David Scadden. Dr. Scadden's role as Co-Director of the Harvard Stem Cell Institute has contributed to the strong partnership between the Center for Regenerative Medicine and Harvard University. www.massgeneral.org Back to top
Lahive & Cockfield Lahive & Cockfield is one of New England's largest intellectual property law firms, focusing on the development and enforcement of intellectual property rights. A leader in patent portfolio, trademark, licensing and intellectual property litigation strategy, the firm protects the technology, innovation and commercial interests of its clients in diverse scientific fields such as biotechnology, medical devices, computational systems, software, chemistry, electronics and engineering. The firm's highly educated and talented staff counsels clients on patent, trademark, copyright, licensing, unfair competition and infringement matters. The firm regularly advises clients in transactional and litigation matters involving competitors, venture capitalists, investment bankers, regulatory authorities and corporate partners. Specialties and Areas of Practice: Patents, Trademarks, Copyrights, Intellectual Property Litigation and Transactions with key practices areas of: antibiotics, bioinformatics, chemistry and chemical engineering, computer systems and software, electrical and electromechanical systems, energy technologies, genomics, medical devices, nanotechnology, pharmaceuticals, proteomics and small molecules. www.lahive.com Back to top
